title: Anti-inflammatory cytokines directly inhibit innate but not adaptive CD8+ T cell functions.
abstract: Virus-specific CD8(+) T cells provide classical adaptive immunity by responding to cognate peptide antigen, but they may also act in an "innate" capacity by responding directly to cytokine stimulation. Here, we examined regulation of these distinct T cell functions by anti-inflammatory cytokines (interleukin-4 [IL-4], IL-10, and transforming growth factor β [TGF-β]). Innate gamma interferon (IFN-γ) production by CD8(+) T cells following exposure to IL-12 plus IL-18, IL-12 plus tumor necrosis factor alpha (TNF-α), or IL-12 plus IL-15 was inhibited by exposure to anti-inflammatory cytokines either before or shortly after stimulation. However, inhibition was not universal, as other activation parameters, including upregulation of CD25 and CD69, remained largely unaltered. In contrast, peptide-specific T cell responses were resistant to inhibition by anti-inflammatory cytokines. This was not due to downregulation of cytokine receptor expression or an inability to signal through cytokine receptors since phosphorylation of STAT proteins remained intact. These results highlight key differences in cytokine-mediated regulation of innate and adaptive T cell functions, which may help balance effective antiviral immune responses while reducing T cell-mediated immunopathology.
  
  
  OBJECTIVE
  This study demonstrates key differences between the regulation of "innate" and "adaptive" CD8(+) T cell functions following activation by innate cytokines or viral peptide. Innate production of IFN-γ by CD8(+) T cells following exposure to IL-12 plus IL-18, IL-12 plus TNF-α, or IL-12 plus IL-15 was inhibited by exposure to anti-inflammatory cytokines (IL-4, IL-10, and TGF-β). However, inhibition was not universal, as other activation parameters, including upregulation of CD25 and CD69, remained largely unaltered. In contrast, peptide-specific T cell responses were resistant to inhibition by anti-inflammatory cytokines. This distinct regulation of innate and adaptive T cell functions may serve to reduce T cell-mediated immunopathology while still allowing for effective antiviral responses at a site of infection.
authors.affiliation: Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Beaverton, Oregon, USA.
authors.forename: Bailey E
authors.initials: BE
authors.lastname: Freeman
authors.affiliation: Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Beaverton, Oregon, USA.
authors.forename: Christine
authors.initials: C
authors.lastname: Meyer
authors.affiliation: Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Beaverton, Oregon, USA slifkam@ohsu.edu.
authors.forename: Mark K
authors.initials: MK
authors.lastname: Slifka
mesh_terms: D056704:Adaptive Immunity / Q000187:drug effects*; D000818:Animals; D015153:Blotting, Western; D018414:CD8-Positive T-Lymphocytes / Q000187:drug effects / Q000276:immunology* / Q000378:metabolism; D002478:Cells, Cultured; D005434:Flow Cytometry; D007113:Immunity, Innate / Q000187:drug effects*; D007249:Inflammation / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D007371:Interferon-gamma / Q000235:genetics / Q000378:metabolism; D016753:Interleukin-10 / Q000494:pharmacology*; D015847:Interleukin-4 / Q000494:pharmacology*; D008213:Lymphocyte Activation / Q000187:drug effects; D051379:Mice; D008807:Mice, Inbred BALB C; D012333:RNA, Messenger / Q000235:genetics; D060888:Real-Time Polymerase Chain Reaction; D020133:Reverse Transcriptase Polymerase Chain Reaction; D016212:Transforming Growth Factor beta / Q000494:pharmacology*
chemical_list: D012333:RNA, Messenger; D016212:Transforming Growth Factor beta; D016753:Interleukin-10; D015847:Interleukin-4; D007371:Interferon-gamma
references.citation: Nat Rev Immunol. 2003 Feb;3(2):133-46
references.pmid: 12563297
references.citation: Adv Immunol. 1980;30:275-331
references.pmid: 6160740
references.citation: J Immunol. 2005 Aug 15;175(4):2357-65
references.pmid: 16081806
references.citation: J Exp Med. 2006 Oct 30;203(11):2461-72
references.pmid: 17030951
references.citation: Immunobiology. 2012 Jan;217(1):74-82
references.pmid: 21903294
references.citation: Trends Microbiol. 2007 Apr;15(4):143-6
references.pmid: 17336072
references.citation: J Exp Med. 1995 Nov 1;182(5):1505-15
references.pmid: 7595220
references.citation: Curr Protoc Immunol. 2012 Feb;Chapter 8:8.17.1-8.17.20
references.pmid: 22314834
references.citation: Science. 1988 May 27;240(4856):1169-76
references.pmid: 3131876
references.citation: J Immunol. 2001 Jan 15;166(2):1097-105
references.pmid: 11145690
references.citation: Rheumatology (Oxford). 2008 Sep;47(9):1269-77
references.pmid: 18621751
references.citation: Int Immunol. 2002 Jun;14(6):535-44
references.pmid: 12039905
references.citation: J Immunol. 2004 Jul 1;173(1):456-62
references.pmid: 15210805
references.citation: J Virol. 2001 Aug;75(16):7399-409
references.pmid: 11462012
references.citation: Proc Natl Acad Sci U S A. 2012 Jun 19;109(25):9971-6
references.pmid: 22665806
references.citation: Front Biosci. 2002 May 01;7:d1247-54
references.pmid: 11991837
references.citation: Adv Virus Res. 2004;63:181-238
references.pmid: 15530562
references.citation: Annu Rev Immunol. 2009;27:591-619
references.pmid: 19132916
references.citation: Cell Rep. 2013 Mar 28;3(3):701-8
references.pmid: 23523350
references.citation: Arch Immunol Ther Exp (Warsz). 2006 Jan-Feb;54(1):15-24
references.pmid: 16642253
references.citation: Annu Rev Immunol. 2002;20:197-216
references.pmid: 11861602
references.citation: J Immunol. 1999 May 1;162(9):5238-46
references.pmid: 10227998
references.citation: Cytokine. 2012 Jan;57(1):191-9
references.pmid: 22078635
references.citation: Immunol Rev. 2004 Dec;202:139-56
references.pmid: 15546391
references.citation: Nature. 2006 Mar 23;440(7083):540-4
references.pmid: 16525420
references.citation: Immunol Res. 2002;26(1-3):309-21
references.pmid: 12403369
references.citation: Nat Med. 2006 Nov;12(11):1301-9
references.pmid: 17041596
references.citation: J Immunol. 1997 Sep 1;159(5):2125-31
references.pmid: 9278298
references.citation: Annu Rev Immunol. 2001;19:683-765
references.pmid: 11244051
references.citation: Eur J Immunol. 2002 Oct;32(10):2807-16
references.pmid: 12355433
references.citation: Eur J Immunol. 2006 Dec;36(12):3090-100
references.pmid: 17111352
references.citation: PLoS Pathog. 2011 Sep;7(9):e1002273
references.pmid: 21980291
references.citation: J Allergy Clin Immunol. 2009 Apr;123(4):758-62
references.pmid: 19348914
references.citation: J Immunol. 1997 Jul 15;159(2):606-13
references.pmid: 9218575
references.citation: Stem Cells. 1994 Sep;12(5):456-65
references.pmid: 7804122
references.citation: Eur J Immunol. 1996 Jul;26(7):1647-51
references.pmid: 8766574
references.citation: Immunity. 2013 Jan 24;38(1):131-9
references.pmid: 23260193
references.citation: J Immunol. 1998 Apr 1;160(7):3188-93
references.pmid: 9531274
references.citation: Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20428-33
references.pmid: 19075244
references.citation: Blood. 2005 Feb 1;105(3):1179-86
references.pmid: 15471952
references.citation: J Exp Med. 2003 Nov 17;198(10):1583-93
references.pmid: 14623912
references.citation: J Immunol. 2004 Dec 1;173(11):6873-81
references.pmid: 15557182